What is the data- and science-driven rationale for focusing on neutrophil-mediated inflammation as a pathobiological target—in addition, let’s say to infectious pathogens—for managing NCFBE?

Anne E. O’Donnell, MD

The Nehemiah and Naomi Cohen Chair in Pulmonary Disease ResearchProfessor of MedicineInterim Chair, Department of MedicineChief, Division of Pulmonary, Critical Care and Sleep MedicineGeorgetown University Medical Center/Medstar Georgetown ...